New Releases from NCBI BookshelfTildrakizumab for treating moderate to severe plaque psoriasis.Tildrakizumab for treating moderate to severe plaque psoriasis.

By admin / September 3, 2025

Post Content

New Releases from NCBI BookshelfBrigatinib for treating ALK-positive advanced non-small-cell lung cancer after crizotinib.Brigatinib for treating ALK-positive advanced non-small-cell lung cancer after crizotinib.

New Releases from NCBI BookshelfOptimising the delivery and impacts of interventions to improve hospital doctors’ workplace wellbeing in the NHS: The Care Under Pressure 3 realist evaluation study.Optimising the delivery and impacts of interventions to improve hospital doctors’ workplace wellbeing in the NHS: The Care Under Pressure 3 realist evaluation study.

Useful Links

NEWREDMARS SKILL AND RESEARCH FOUNDATION

Registration No: 771800548 Contact Number : +91-8249516996

Publication
Skill Development
Blog Writing

Research
Awareness Camp
Digital Research

Ngo Darpan
Service
Donation

Term and Condition
Privacy Policy
Disclaimer

Scroll to Top

New Releases from NCBI BookshelfTildrakizumab for treating moderate to severe plaque psoriasis.Tildrakizumab for treating moderate to severe plaque psoriasis.

Leave a Comment Cancel Reply

Useful Links

NEWREDMARS SKILL AND RESEARCH FOUNDATION

©2021-2024. Newredmars Skill and Research Foundation. All Rights Reserved.